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Abstract   
The role of hepatobiliary transporters in drug-induced liver injury remains poorly understood. 
Various in vivo and in vitro biological approaches are currently used for studying hepatic 
transporters; however, appropriate localization and functional activity of these transporters 
are essential for normal biliary flow and drug transport. Human hepatocytes (HH) are 
considered as the most suitable in vitro cell model but erratic availability and inter-donor 
functional variations limit their use. In the present work, we aimed to compare localization of 
influx and efflux transporters and their functional activity in differentiated human HepaRG 
hepatocytes with fresh HH in conventional (CCHH) and sandwich (SCHH) cultures. All 
tested influx and efflux transporters were correctly localized to canalicular (BSEP, MRP2, 
MDR1, MDR3) or basolateral (NTCP, MRP3) membrane domains and were functional in all 
models. Contrary to other transporters, NTCP and BSEP were less abundant and active in 
HepaRG cells, cellular uptake of taurocholate was 2.2- and 1.4-fold and bile excretion index 
2.8-and 2.6- fold lower, than in SCHH and CCHH respectively. However, when taurocholate 
canalicular efflux was evaluated in standard and divalent cation-free conditions in buffers or 
cell lysates, the difference between the three models did not exceed 9.3%. Interestingly, cell 
imaging showed higher bile canaliculi contraction/relaxation activity in HepaRG hepatocytes 
and larger bile canaliculi networks in SCHH. Altogether, our results bring new insights in 
mechanisms involved in bile acids accumulation and excretion in HH and suggest that 
HepaRG cells represent a suitable model for studying hepatobiliary transporters and drug-
induced cholestasis. 
 
Key words: Hepatobiliary transporters, membrane localization, transporter activity, HepaRG 
hepatocytes, human hepatocytes. 
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Abbreviations: BEI, Bile excretion index; BSEP, Bile salt export pump; CDFDA, 5(6)-
Carboxy-2′,7′-dichlorofluorescein diacetate; CCHH, conventional culture of human 
hepatocytes, HH, human hepatocytes; JC-1, 5,5′,6,6′-Tetrachloro-1,1′,3,3′-
tetraethylbenzimidazolo carbocyanine iodide; MDR, multidrug resistance protein; MK571, 5-
(3-(2-(7-Chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid 
sodium salt hydrate; MRP, multidrug resistance-associated protein; NTCP, Na
+
-dependent 
taurocholate co-transporting polypeptide; OATP, organic anion transporting polypeptide; 
OCT-1, organic cation transporter 1; PBS, phosphate buffered saline; SCHH: sandwich-
cultured human hepatocytes; TCA, taurocholic acid. 
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Introduction 
Hepatocytes are highly polarized cells exhibiting specialized apical (canalicular) and sinusoidal 
(basolateral) domains. They import and export a variety of exogenous and endogenous substrates 
largely via membrane transporters that are divided into two major groups: influx transporters 
mediating cellular uptake of appropriate substrates and efflux transporters responsible for their 
excretion into bile canaliculi or blood (Giacomini et al., 2010). Bile acids and drugs are their 
main substrates; 95% of bile acids secreted into bile are reabsorbed in the ileum; diffused across 
the enterocyte to the basolateral membrane, exported into portal blood circulation, extracted at 
the hepatocyte sinusoidal membrane, and re-secreted into bile contributing therefore to bile 
formation through the so-called entero-hepatic circulation (Hofmann, 1999).  
Hepatic uptake of biliary constituents at the sinusoidal domain of hepatocytes is mediated by 
both sodium-dependent and independent mechanisms (Nathanson and Boyer, 1991). While 
sodium-independent uptake of bile salts is carried by members of the organic anion transporting 
polypeptide family (OATPs/SLCOs), sodium-dependent uptake is mediated by the Na
+
- 
taurocholate cotransporting polypeptide (NTCP/ SLC10A1) that represents the most relevant 
uptake system. It accounts for the uptake of the major part of conjugated bile acids and less than 
half of unconjugated bile acids (Kullak-Ublick et al., 2000;  Meier and Stieger, 2002). Bile salts 
are then carried across the hepatocyte and secreted into bile via canalicular transporters. 
Canalicular transport of bile constituents is mainly mediated by ABC superfamily transporters: 
bile salt export pump (BSEP/ABCB11), multidrug resistance associated protein 2 
(MRP2/ABCC2), P-glycoprotein (multidrug resistance protein 1 MDR1/ABCB1), phospholipid 
flippase (MDR3/ABCB4) and breast cancer resistance protein (BCRP/ABCG2). While BSEP 
exports monovalent bile salts and is responsible for bile salt-dependent flow, MRP2 excretes 
divalent bile salts, glutathione and its conjugates, generating therefore the major part of bile salt 
independent bile flow (Kullak-Ublick et al., 2000). MDR1 has been shown to transport 
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amphipathic organic cations while MDR3 translocates phosphatidylcholine from the inner to the 
outer leaflet of the canalicular membrane (Lefebvre et al., 2009). An alternative efflux system 
belonging to the multidrug resistance protein subfamily, represented by MRP3 and MRP4, is 
localized to the basolateral membrane domain and provides an alternative excretory route for bile 
constituents when their canalicular excretion is impaired (Trauner and Boyer, 2003).  
Impairment of bile flow is called cholestasis and may be caused by a functional impairment of  
canalicular secretory processes, which in turn results in an intracellular accumulation of 
cholephilic compounds such as bile salts (Trauner et al., 1998). Intrahepatic cholestasis of 
pregnancy and drug-induced cholestasis are acquired forms of cholestasis (Pauli-Magnus et al., 
2010). Drug-induced cholestasis may lead to drug-induced liver injury in humans. In many cases 
of acquired forms of cholestasis activity and cellular distribution of hepatobiliary transporters are 
altered. Other mechanisms, such as altered cell polarity as a consequence of mistargeting of 
intracellular transport vesicles, cytoskeletal modification, disrupted cell-cell junctions or 
deregulated signaling pathways may be involved in acquired cholestasis (Trauner and Boyer, 
2003). Finally, oxidative stress as a primary causative agent and/or as an aggravating factor has 
been linked to cholestatic liver injury (Antherieu et al., 2013;  Copple et al., 2010;  Perez et al., 
2006;  Roma and Sanchez Pozzi, 2008). 
 Although major progress has been made in the knowledge of transporters, their regulation and 
interactions with drugs and substrates, their role in drug-induced liver injury, in particular drug-
induced cholestasis, requires further investigations (Corsini and Bortolini, 2013;  Liu et al., 
2014). Various in vivo and in vitro biological approaches are currently used for studying hepatic 
transporters. Sandwich-cultured primary hepatocytes are considered as the most appropriate cell 
model to mimic the hepatobiliary secretory process (De Bruyn et al., 2013); since major species-
differences have been reported in this process, the use of sandwich-cultured primary human 
hepatocytes (SCHH) is desirable (Guguen-Guillouzo and Guillouzo, 2010;  Swift et al., 2010). 
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Recent studies have shown that cholestasis can be induced by drugs in human HepaRG cells, a 
human liver cell line expressing features of mature hepatocytes and exhibiting typical bile 
canaliculi. These findings suggest that HepaRG cells may be useful to mechanistically better 
understand drug-induced alterations of bile acids influx and efflux (Antherieu et al., 2013;  
Sharanek et al., 2014). Whether the transport process in this cell model compares well with that 
in primary human hepatocytes in conventional or sandwich configuration remains currently 
unanswered. In the present work, we showed that cellular localization and functional activity of 
the main hepatobiliary transporters were comparable in HepaRG cells and primary human 
hepatocytes. 
 
Materials and Methods 
Reagents.  
Phalloidin fluoprobe was purchased from Interchim (Montluçon, France), [
3
H]-taurocholic acid 
([
3
H]-TCA) was from Perkin Elmer (Boston, MA), verapamil, 5-(3-(2-(7-Chloroquinolin-2-
yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid sodium salt hydrate (MK571) 
and 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate (CDFDA) were from Sigma
 
(St. Quentin 
Fallavier, France). 5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethylbenzimidazolo carbocyanine iodide 
(JC-1 dye) was obtained from Invitrogen-Molecular probes (Saint Aubin, France). Hoechst dye 
was from Promega (Madison, Wisconsin, USA). All primary antibodies, except BSEP and NTCP 
antibodies (gifts from Dr B. Stieger), were from Abcam (Cambridge, UK). Secondary antibodies 
were from Santa Cruz Biotechnology (Santa Cruz, USA). All other reagents were from Sigma. 
Cell cultures 
HepaRG cells were seeded at a density of 2.6×10
4 
cells/cm
2
 in Williams’ E medium 
supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 mg/mL streptomycin, 5 
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mg/mL insulin, 2 mM glutamine, and 50 mM hydrocortisone hemisuccinate. After 2 weeks, 
HepaRG cells were shifted to the same medium supplemented with 1.7 % dimethyl sulfoxide for 
2 additional weeks in order to obtain confluent differentiated cultures. At that time, cultures 
contained equal proportions of hepatocyte-like and progenitors/primitive biliary-like cells (Cerec 
et al., 2007). 
Human hepatocytes were obtained from Biopredic International (St Gregoire, France). They 
were isolated by collagenase perfusion of histologically normal liver fragments from 8 adult 
donors undergoing resection for primary and secondary tumors (Guguen-Guillouzo et al., 1982). 
Primary cultures were obtained by hepatocyte seeding at a density of 1.5 x 10
5
 cells/cm
2
 onto 
collagen-precoated plates in Williams’ E medium supplemented with 10% fetal bovine serum, 
100 units/µl penicillin, 100 µg/ml streptomycin, 1 µg/ml insulin, 2 mM glutamine, and 1 µg/ml 
bovine serum albumin. The medium was discarded 12 h after cell seeding, and cultures were 
thereafter either maintained in the same medium as for HepaRG cells and designated as 
conventional HH (CCHH) cultures, or after 24 to 48h washed with cold medium and overlaid 
with matrigel at a concentration of 0.25 mg/mL in ice-cold Williams’ E medium for the 
preparation of SCHH cultures. The medium of both CCHH and SCHH cultures was renewed 
every day. CCHH and SCHH cultures were prepared from the same donors and analysed in 
parallel. SCHH cultures were used after at least 3 day-matrigel overlay. 
Immunolabeling  
Cells were washed with warm phosphate buffered saline (PBS), fixed with either methanol for 
15 minutes at -20°C or with 4% paraformaldehyde for 20 minutes at 4°C and then washed three 
times with cold PBS. After paraformaldehyde fixation, cells were permeabilized for 20 minutes 
with 0.3% Triton in PBS followed by 1-hour incubation in PBS containing 1% bovine serum 
albumin and 5% normal donkey serum. Cells were then incubated overnight with primary 
antibodies directed against NTCP (Kullak-Ublick et al., 1997) and BSEP (Noe et al., 2002) 
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diluted at 1/200 and 1/50 respectively, MRP2 (M2III-6, Abcam) diluted at 1/100, MRP3 (M3II-
9, Abcam), MDR1 (JSB-1, Abcam) or MDR3 (P3II-26, Abcam) diluted at 1/50 in PBS 
containing 1% bovine serum albumin and 5% normal donkey serum. After washing with cold 
PBS cells were incubated for 2 hours with goat- or rabbit Alexa fluor 488 labeled secondary 
antibodies in the same buffer as described above. Finally, cells were again washed with cold PBS 
and incubated with Hoechst and phalloidin in PBS for 20 minutes for F-actin and nuclei labeling 
respectively. Immunofluorescence images were detected by Cellomics ArrayScan VTI HCS 
Reader (Thermo Scientific, New Hampshire, USA). 
F-actin distribution 
After fixation of cells as described above, cytoskeletal F-actin was localized using phalloidin 
fluoprobe SR101 (200 U/ml) diluted at 1/100 for 20 minutes as described previously (Pernelle et 
al., 2011). Nuclei were labeled with 5 ng/ml Hoechst dye in parallel to F-actin labeling. 
Functional activity of multidrug resistance proteins  
The JC-1 metachromatic dye is translocated across the canalicular membrane via MDRs, 
particularly MDR1 (Legrand et al., 2001). It does not accumulate in differentiated HepaRG 
hepatocytes without preincubation with verapamil, an inhibitor of MDRs (Pernelle et al., 2011). 
Briefly, cells were incubated in the presence or absence of 50µM verapamil (an inhibitor of 
MDRs) for 30 minutes and then verapamil was washed out with warm PBS before 30 minutes 
incubation with 7µM JC-1 at 37°C. Imaging was done by Cellomics ArrayScan VTI HCS 
Reader. Above a critical intracellular concentration, JC-1 forms dimers that display a specific red 
emission whereas the monomers display a green emission.   
Na
+
-dependent taurocholate co-transporting polypeptide activity.  
Activity of the NTCP transporter was measured through determination of radiolabeled TCA in 
cellular layers (cells plus bile canaliculi) (Antherieu et al., 2013). Briefly, HepaRG cells and 4-5 
days CCHH and SCHH cultures were washed twice with PBS and then incubated with [
3
H]-TCA 
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for 30 minutes in a buffer containing or not sodium ions. Cells were then washed twice with PBS 
and lysed with 0.1N NaOH. Accumulation of the radiolabeled substrate in cellular layers was 
determined through scintillation counting. 
Efflux of taurocholic acid 
HepaRG cells and 4-5 days CCHH and SCHH were exposed to [
3
H]-TCA for 30 minutes, and 
then washed with PBS. Efflux of radiolabeled TCA was assessed for 30 minutes in either 
standard or Ca
2+
- and Mg
2+
-free buffer. Cells were then scraped in 0.1N NaOH and accumulation 
of radiolabeled substrate into cells + bile canaliculi (in the presence of Ca
2+
- and Mg
2+
-
 
ions) and 
into cells only (in the absence of Ca
2+
- and Mg
2+
-
 
ions) was measured through scintillation 
counting to evaluate TCA efflux. Absence of divalent cations promotes disruption of tight 
junctions and induces bile canaliculi opening (Liu et al., 1999). This technology, called B-
CLEAR
® 
technology, is patented and exclusively licensed to the Qualist Transporter Solutions 
company, Durham, NC.  
To determine the contribution of passive diffusion to TCA efflux, cells were incubated in parallel 
in either standard or Ca
2+
- and Mg
2+
-free buffer for 30 minutes at 37°C or in standard buffer at 
4°C after TCA uptake. Radiolabeled TCA was measured in all buffers and cells in order to 
calculate the relative contribution of diffusion and basolateral and canalicular efflux of TCA 
(Jemnitz et al., 2010;  Liu et al., 1999;  Marion et al., 2012). Three different methods were used 
for calculation of efflux activity. 
First, biliary excretion index (BEI) (method I), which represents the percentage of [
3
H]-TCA that 
is excreted into bile canaliculi, was calculated using the following equation: BEI = 
[(Accumulation Cells + Bile canaliculi – Accumulation Cells)/Accumulation Cells + Bile canaliculi] ×100% (Liu 
et al., 1999). 
The second method (method II) was based on the accumulation of TCA, after a 30 minute-efflux 
period, in cell lysates in the presence and absence of divalent cations (Liu et al., 1999). Using 
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TCA accumulation in cell lysates, diffusion, and basolateral and canalicular efflux were 
calculated using the following equations: 
T0 = Total TCA uptake into the cell layer after 30 minutes incubation in standard buffer. 
Total efflux = T0 – Accumulation Cells at 37°C 
Diffusion = (T0 – Accumulation Cells + Bile canaliculi at 4°C) ×100% / Total efflux 
The value “T0 - Accumulation Cells + Bile canaliculi at 4°C” represents the radiolabeled TCA that 
diffused out of cell layer. 
Basolateral efflux = [(T0 – Accumulation Cells + Bile canaliculi at 37°C) ×100% / Total efflux]-
Diffusion. 
The value “T0 – Accumulation Cells + Bile canaliculi at 37°C” represents the radiolabeled TCA that is 
excreted in the medium either by basolateral transporters or by passive permeability. 
Canalicular efflux = 100% – (Basolateral Efflux + diffusion)  
The third method (method III) was based on radiolabeled TCA measured after a 30 minute-efflux 
period in standard and Ca
2+
- and Mg
2+
-free buffer (Jemnitz et al., 2010). Radioactivity in 
standard buffer at 37°C represented basolateral efflux and passive diffusion of TCA while that in 
Ca
2+
- and Mg
2+
-free buffer corresponded to canalicular efflux in addition to basolateral efflux 
and passive diffusion. 
Total efflux = Radioactivity in Ca
2+
 and Mg
2+
-free buffer at 37°C 
Diffusion = Radioactivity in standard buffer at 4°C ×100% /Total efflux 
Basolateral efflux = (Radioactivity in standard buffer at 37°C - Radioactivity in standard buffer 
at 4°C)×100% / Total efflux 
Canalicular efflux = (Radioactivity in Ca
2+
- and Mg
2+
-free buffer at 37°C - Radioactivity in 
standard buffer at 37°C)× 100% /Total efflux 
CDF excretion. 
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Cells were washed with warm PBS, pre-incubated for 20 minutes in the presence or absence of 
30µM MK571, a specific inhibitor of MRP2, before addition of 2µM CDFDA for 30 minutes at 
37°C in either standard or Ca
2+
- and Mg
2+
-free buffer. Upon hydrolysis of CDFDA by 
intracellular esterases, CDF is secreted into the bile canaliculi by membrane transporters, 
particularly MRP2 (Zamek-Gliszczynski et al., 2003). Cells were then washed with PBS and 
imaging was done using inverted microscope Zeiss Axiovert 200M and AxioCam MRm. 
Time-lapse imaging 
Phase-contrast images of HepaRG cells, conventional HH and SCHH were captured each 
minute, using time-lapse phase-contrast videomicroscopy. The inverted microscope Zeiss 
Axiovert 200M was equipped with a thermostatic chamber (37°C and 5% CO2) to maintain the 
cells under normal culture conditions. Images were captured by AxioCam MRm camera with a 
20x objective and the mosaic tool of the microscope, which enabled the automated acquisition of 
multi-image mosaics at the defined positions.  
Statistical analysis 
One-way ANOVA with Bonferroni's multiple comparison test (GraphPad Prism 6.00) was 
performed to compare data between the three cell models. Each value corresponded to the mean 
±
 
standard deviation (SD) of at least three independent experiments. Data were considered 
significantly different
 
when p < 0.05.  
Results 
HepaRG cell and human hepatocyte polarity  
Under phase-contrast microscopy, HepaRG hepatocytes and human hepatocytes either in 
conventional culture or in a sandwich configuration formed clusters with well-defined 
intercellular structures resembling characteristic bile canaliculi (Fig.1A).  
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Polarity of the different hepatocyte models was analyzed by phalloidin fluoprobe labeling of 
cytoskeletal F-actin. Labeling was particularly abundant in the pericanalicular areas which 
defined multiple shapes of bile canaliculi in primary hepatocytes. In SCHH, these structures 
showed a time-dependent progression in the formation of a branched bile canalicular network 
and were more elongated than in corresponding CCHH, especially after 4-5 days (Fig. 1B). 
HepaRG cells also showed abundant pericanalicular cytoskeletal F-actin and sparse network of 
microfilaments beneath the plasma membrane defining the cell shape. At the electron 
microscopic level bile canaliculi appeared to be surrounded by large tight junctional complexes 
in HepaRG hepatocytes (Fig.1C). Accordingly, the mean surface of bile canaliculi networks was 
estimated by measuring CDF-labeled lumen surfaces using vHCS.scan (V6.2.0) cellomics 
software and found to be 1.7- and 1.3- fold higher in SCHH than in HepaRG cell and CCHH 
cultures respectively (Fig. 2).  
Moreover, dynamics of bile canaliculi was assessed by time-lapse imaging, which allowed to 
analyze living cells directly over time. Some bile canaliculi showed contractions and relaxations 
in HepaRG cells, indicating that they were active and periodically clearing accumulated 
products. No synchronism was observed, even within a hepatocyte cluster (Fig. 3A). Such 
contractions and relaxations were slower in conventional HH (Fig. 3B) and difficult to visualize 
in SCHH, likely due to the elongated shape of bile canaliculi and the upper matrigel layer.  
Cellular localization of bile acid transporters  
Localization of several main hepatobiliary transporters was assessed by immunofluorescence 
staining in HepaRG cells as well as in 4-5 days SCHH and CCHH. Importantly, in HepaRG cell 
cultures transporter immunolabeling was restricted to hepatocyte-like cells; no transporter was 
visualized in primitive biliary cells.  
Influx transporter  
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NTCP was localized to the sinusoidal membrane domain in CCHH and SCHH. However, 
immunolabeling was weaker in the former. Similarly to SCHH, HepaRG cells showed a faint 
sinusoidal membrane staining and in addition a diffuse intracytoplasmic labeling for NTCP (Fig. 
4).  
Efflux transporters 
Basolateral domain: MRP3 was exclusively localized to the sinusoidal plasma membrane 
domain in all the liver cell models with a more intense labeling in HepaRG cells (Fig. 4).  
Canalicular domain: Four canalicular transporters, BSEP, MRP2, MDR1 and MDR3, were 
immunolocalized in human hepatocytes and HepaRG cells (Fig. 4). In human hepatocytes, BSEP 
co-localized with cytoskeletal F-actin and was detected on canalicular membranes. It displayed a 
faint canalicular immunolabeling in HepaRG cells with in addition, a slight heterogeneous 
intracytoplasmic labeling (Supplementary Fig. 1). The other canalicular transporters, MRP2, 
MDR1 and MDR3, were well visualized, exclusively on canalicular membranes in the three liver 
cell models, with a more intense labeling of MRP2 and MDR1 in HepaRG cells (Fig. 4).  
Transporter activities 
Sodium-dependent activity of NTCP 
To assess whether the influx of TCA was sodium-dependent, HepaRG cells and HH were 
incubated for 30 minutes with [
3
H]-TCA in the presence or absence of sodium ions. 
Accumulation of radiolabeled TCA in cellular layers was then measured. Uptake of TCA by 
HepaRG cells was more than 42-fold greater in presence of sodium demonstrating that NTCP 
displayed a sodium-dependent activity as in the in vivo situation (Fig. 5A). It was 33 and 15 
times greater in presence of sodium in sandwich and conventional HH cultures respectively. 
When measured per hepatocyte NTCP activity was around 2.2- and 1.4-fold higher in SCHH and 
CCHH than in HepaRG cells respectively (Fig. 5B). 
Activity of efflux transporters 
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Efflux of CDF and [
3
H]-TCA, substrates of MRP2 and BSEP respectively, was assessed in 
standard and Ca
2+
- and Mg
2+
-free buffer. After 30 minute-incubation with CDFDA in standard 
buffer, fluorescent CDF was visualized in bile canaliculi of both HepaRG cells and 4-5 days 
SCHH and CCHH cultures (Fig. 6). By contrast, absence of sharp canalicular labeling was 
noticed in Ca
2+
- and Mg
2+
-free buffer, particularly in SCHH. Although many bile canaliculi were 
still labeled in HepaRG cells despite the depletion in divalent cations, the total number of 
fluorescent canaliculi was clearly reduced. No well-defined canalicular labeling was observed 
when incubation was performed in the presence of MK571, an inhibitor of MRP2 and the two 
other major ABC transporters MDR1 and BCRP (Matsson et al., 2009).  
Canalicular excretion of taurocholate was first quantified using BEI values (method I). BEI of 
TCA represented 26.6, 70.9 and 74.2% in HepaRG cells, CCHH and SCHH respectively (Table 
1). In order to determine the relative contribution of diffusion, and basolateral and canalicular 
efflux of TCA, two other modes of calculation of TCA efflux were also used based on 
measurement of radiolabeled TCA in cell lysates and buffers (after incubation in buffer 
containing or not Ca
2+
 and Mg
2+
) at 4 and 37°C. Incubation of cells at 4°C blocked all active 
transport systems, thereby allowing determination of the percentage of TCA released by 
diffusion (passive permeability). When calculation was based on the accumulation of 
radiolabeled TCA in cell lysates (method II) after incubation in a buffer containing or not 
divalent cations, canalicular efflux, basolateral efflux and diffusion were found to contribute 
nearly equally to TCA release in HepaRG cells and CCHH while in SCHH canalicular and 
basolateral efflux were around 6-8% higher and diffusion was 12-16% lower compared to the 
two other cell models (Table 1). When radiolabeled TCA was quantified in incubation buffers 
(method III) containing or not Ca
2+
 and Mg
2+
 a higher contribution of basolateral efflux was 
observed; it became the major route of TCA excretion in HepaRG cells, SCHH and HH, i.e. 
57.6, 43 and 35% respectively, compared to the canalicular efflux that represented 28.5, 37.9 and 
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26.3% respectively. The contribution of passive permeability to total TCA excretion was clearly 
lower in HepaRG cells and SCHH (13.9 and 19.1% respectively) while it still was the major 
route in CCHH cultures (38.8%). Noteworthy, when basolateral efflux and diffusion values 
obtained from measurements in cell lysates (method II) were summed, their percentages 
represented 68.7, 61.5 and 69.2% of total TCA efflux in HepaRG, SCHH and CCHH 
respectively; those summed from measurements in buffers (method III) gave comparable 
percentages representing 76.1, 62.1 and 73.7% respectively.  
MDRs activity  
Incubating HepaRG cells with JC-1 dye resulted in red and green cell areas in the same 
microscopic field (Fig. 7). The red cell areas corresponded to primitive biliary cells, which did 
not express MDRs while green ones represented the hepatocytes, which displayed MDRs 
proteins across their canalicular plasma membrane. By transporting JC-1 out of the cells, MDRs 
did not allow the dye to reach critical concentration to form dimers. Only pre-incubation with 
verapamil, an inhibitor of MDRs, before JC-1 exposure resulted in red fluorescence in both cell 
types.  
 
Discussion  
While previous studies have demonstrated that the majority of hepatobiliary transporters (OCT1, 
OATP1B1, OATP2B1, NTCP, MRP2, MRP3, BSEP and MDR1) are expressed in differentiated 
HepaRG cells, their distribution and activity are still poorly documented (Antherieu et al., 2010;  
Kotani et al., 2012;  Le Vee et al., 2013;  Szabo et al., 2013). In the current study, we compared 
the localization and functional activity of the main membrane transporters in HepaRG cells and 
human hepatocytes in conventional and sandwich configuration. The major hepatobiliary 
transporters including BSEP and NTCP, were visualized by immunolabeling and found to be 
correctly distributed on canalicular and basolateral membrane domains respectively, and to be 
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functional in the three liver cell models. Noteworthy, primitive biliary HepaRG cells did not 
express detectable transporter mRNA and protein of any tested transporter and accordingly, did 
not accumulate TCA (Sharanek et al., 2014). 
A basolateral NTCP localization together with a sodium-dependent activity (Kotani et al., 2012) 
has been evidenced in both HepaRG cells and primary human hepatocytes. Compared to CCHH 
and SCHH, HepaRG cells showed weaker labeling and activity of NTCP which is in agreement 
with lower corresponding mRNA levels as previously measured in these cells compared to 
freshly isolated or 1-day human hepatocytes (Antherieu et al., 2012;  Le Vee et al., 2013). By 
contrast, other authors found that NTCP transcripts and protein levels were more than two-fold 
higher in HepaRG cells than in cryopreserved primary human hepatocytes (Kotani et al., 2012). 
This discrepancy likely resulted from the use of cryopreserved human hepatocytes in the latter 
study. Indeed, a marked reduction of protein content and activity of NTCP and other influx 
transporters has recently been reported in human hepatocytes associated with the freeze/thaw 
process (Lundquist et al., 2014).  
Immunolabeling of BSEP showed canalicular distribution of this transporter in HH whatever 
their mode of culture, in agreement with its apical localization in human liver biopsies and rat 
hepatocyte couplets (Boaglio et al., 2010;  Zollner et al., 2001). Although much weaker than in 
human hepatocytes, in accordance with lower corresponding mRNA levels (Antherieu et al., 
2012;  Le Vee et al., 2013), BSEP was also detected on canalicular membranes of HepaRG cells. 
Moreover, noticeably, intracellular labeling was in addition observed in HepaRG cells as 
previously reported for rat hepatocytes in situ and for the WIF-B cell line (Gerloff et al., 1998;  
Gradilone et al., 2005;  Soroka et al., 1999). It has been emphasized that intracellular BSEP is 
capable of trafficking within minutes to the canalicular membrane when the demand for BSEP 
increased (Kipp and Arias, 2002). To our best knowledge, the present study is the first 
immunolocalization of BSEP in HepaRG cells and primary human hepatocyte cultures. 
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Localization of MRP2, MDR1 and MDR3 was restricted to canalicular membranes while MRP3 
was exclusively localized to the basolateral membrane domain in both HepaRG cells and human 
hepatocytes. Although no quantification was performed, immunolabeling of MRP2, MDR1 and 
MRP3 appeared to be more intense in HepaRG cells than in HH, in agreement with previous 
studies showing overexpression of these genes at the transcriptional level in the former 
(Antherieu et al., 2012;  Le Vee et al., 2013). The present study provided clear evidence that the 
canalicular efflux transporters BSEP, MRP2 and MDRs were functional and that cholephilic 
substances could accumulate in bile canaliculi. BSEP and MRP2 substrates were demonstrated 
inside bile canaliculi of the three hepatocyte models and functional activity of MDR1 was 
evidenced in HepaRG hepatocytes using the JC-1 metachromatic dye of which continuous 
excretion by MDR1 was prevented following pre-incubation with the MDR1 inhibitor verapamil.  
BEI values (method I) were higher in SCHH and CCHH than in HepaRG cells, i.e. 74.2, 70.9 
and 26.6% respectively. Using other modes of calculation based on radioactivity measured in 
cell lysates (method II) and incubation buffers (method III) (Jemnitz et al., 2010;  Liu et al., 
1999), contribution of canalicular efflux to total excretion of TCA was found to be comparable to 
the BEI in HepaRG cells, representing 31.3 and 28.5% respectively. The BEI found in the 
present study is close to that previously reported by others (Le Vee et al., 2013). Similarly, the 
highest values found in SCHH were comparable to those previously obtained by Marion and 
coworkers (Marion et al., 2007). However, in another study, Marion and co-workers found much 
lower BEI values in SCHH (Marion et al., 2012). Such large differences (41.7 versus 73.2%) 
could reflect the well-known inter-individual variations of functional activities in HH. It has been 
previously reported that efflux of taurocholate was around 40-50% greater in SCHH than in 
CCHH (Kostrubsky et al., 2003). The comparable BEI values found in the two primary 
hepatocyte models in the present study could be explained by the use of fresh cells and our 
experimental conditions, including the type of culture medium and the choice of 4-5 days of 
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culture before analysis of bile acid excretion. At that time, primary human hepatocytes express 
high levels of drug metabolizing enzymes activities and other functions (Abdel-Razzak et al., 
1993). 
The lower BEI in HepaRG cells compared to SCHH and CCHH could have several non-
exclusive explanations. First, an attenuated NTCP and BSEP activity in comparison to HH 
regardless their mode of culture. In accordance, when the amount of accumulated TCA in cell 
layers was calculated per hepatocyte, it was 2.2- and 1.4- fold higher in sandwich and standard 
cultured HH than in HepaRG hepatocytes respectively. Such attenuated NTCP and BSEP 
activity is supported by low corresponding mRNA levels (Antherieu et al., 2012;  Le Vee et al., 
2013) and results in reduced TCA uptake and canalicular excretion. These low NTCP and BSEP 
activities could explain the 2.8-fold lower BEI values compared to SCHH. Second, the 
overexpression of MRP3 mRNA in HepaRG cells (Antherieu et al., 2012;  Le Vee et al., 2013) 
could explain the higher contribution of this route to total excretion of TCA. Third, the smaller 
size of the bile canaliculi network and the higher contraction/relaxation activity promoting a 
continuous discharge of their content. Forth, an incomplete opening of HepaRG bile canaliculi in 
cation-free buffer, because of the large size of tight junctions as observed under electron 
microscopy. This hypothesis is based on the sharp CDF-fluorescent labeling in many bile 
canaliculi in the absence of divalent cations in HepaRG cells whereas such labeling was nearly 
completely absent in SCHH. Noticeably, a 10-15% increase in canalicular TCA and CDF efflux 
was measured by using higher concentrations of the divalent cation chelator EGTA (data not 
shown). As a consequence, total and canalicular efflux were likely slightly underestimated in 
HepaRG cells.  
Noteworthy, when canalicular efflux was estimated from measurement of radioactivity in either 
cell lysates (method II) or buffers (method III) the difference between HepaRG cells and SCHH 
did not exceed 9.3% and comparable values were found in HepaRG cells and CCHH. These 
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limited differences between the three cell models compared to the differences in BEI values 
could probably be explained by the fact that the values obtained from cell lysates and buffers are 
based on total TCA efflux and not on TCA intracellular and bile canaliculi content (Liu et al., 
1999). 
The contribution of passive membrane permeability was also estimated by measuring 
radioactivity in either cell lysates or buffers after a 30 minutes incubation at 4°C (Jemnitz et al., 
2010). High values of passive permeability reaching nearly 40% were obtained with CCHH (in 
both lysates and buffers) and with HepaRG cells (cell lysates) while these values were much 
lower in SCHH (in both lysates and buffers representing 19.1 and 23.4% respectively) and in 
HepaRG cells (in buffers representing 19.1%). Moreover, large inter-assays variations were 
apparent in the two human hepatocyte models. Noticeably, around 30% diffusion was also 
reported with rat hepatocytes which have a higher basolateral efflux activity than human 
hepatocytes (Jemnitz et al., 2010). All these data lead to the conclusion that the experimental 
conditions used to evaluate passive permeability may result in its overestimation. This could at 
least partly be due to excessive release of TCA, for instance during cell detachment from the 
culture dishes. Obviously, analysis of passive permeability in the three liver cell models deserves 
further investigations. 
In conclusion, the present study demonstrated that HepaRG hepatocytes displayed a set of main 
hepatobiliary transporter proteins (NTCP, MRP3, BSEP, MRP2, MDR1 and MDR3) at the 
appropriate membrane domains and all the tested ones (NTCP, BSEP, MDRs) were functional as 
in primary HH. To our best knowledge, the present work is the first comparative localization and 
functional activity evaluation of the main membrane transporters in HepaRG cells and primary 
human hepatocytes. Analysis of basolateral and canalicular TCA efflux showed that the 
excretion mode of TCA was comparable in both cell models. However, some quantitative 
differences in relative canalicular and basolateral efflux were observed; they could be explained 
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not only by variations in the levels of NTCP, BSEP and basolateral efflux transporters but also 
by the size of the bile canaliculi network and its constriction/relaxation activity. HepaRG 
hepatocytes have already shown their unique interest for analyzing bile canaliculi function and 
response to cholestatic agents (Antherieu et al., 2013;  Bachour-El Azzi et al., 2014;  Sharanek et 
al., 2014). The data reported in the present study bring further information on mechanisms by 
which bile acids can accumulate and be excreted in either HepaRG cells and primary 
hepatocytes. Altogether our data support the conclusion that with the advantages to be a 
reproducible and easy to handle cell model, HepaRG hepatocytes represent a unique model for 
investigating hepatobiliary transport and xenobiotic effects on canalicular efflux and cholestasis-
induced features. 
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Table 1: Different modes of calculation of taurocholic acid efflux in the three human 
liver cell models.  
  HepaRG  SCHH CCHH 
Bile Excretion Index (BEI) (%) 26.58 ± 7.26 74.15 ± 8.67* 70.94 ± 13.38* 
 
 
Cell lysates 
Canalicular efflux (%) 31.26 ± 9.75 38.53 ± 15.75 30.77 ± 9.10 
Basolateral efflux (%) 32.73 ± 7.34 38.05 ± 18.88 30.06 ± 1.11 
Diffusion (%) 36.02 ± 6.98 23.42 ±14.57 39.17 ± 8.37 
Basolateral + Diffusion (%) 68.75 ± 9.75 61.47 ± 15.75 69.23 ± 9.10 
 
 
Buffers 
Canalicular efflux (%) 28.52 ± 4.77 37.86 ± 24.63 26.27 ± 9.22 
Basolateral efflux (%) 57.58 ± 6.36 43.00 ± 24.16 34.95 ± 5.69 
Diffusion (%) 13.89 ± 3.47 19.14 ± 11.76 38.77 ± 14.91 
 Basolateral + Diffusion (%) 71.47 ± 6.27 62.14 ± 24.63 73.72 ± 9.22 
 
HepaRG cells and 4-5 days sandwich and conventional cultures of human hepatocytes were 
exposed to [
3
H]- TCA for 30 minutes to induce uptake of TCA. After 30 minutes incubation 
in standard and Ca
2+
- and Mg
2+
-free buffer at 4 and 37°C, TCA efflux was determined by 
measuring radioactivity in cell lysates and buffers. The values measured in HepaRG cells 
(HepaRG), and sandwich (SCHH) and conventional (CCHH) human hepatocyte cultures are 
expressed as bile excretion index (BEI) or as percentages of total efflux +/- SD (n ≥ 3) and 
were calculated as described in materials and methods. CCHH and SCHH cultures of fresh 
human hepatocytes were prepared from the same donors and analyzed in parallel. 
 
 
 at U
niversitaet Zuerich on M
arch 3, 2015
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
Legends to Figures 
Fig. 1. Bile canaliculi networks in HepaRG cell and human hepatocyte cultures. (A) Bile 
canaliculi structures (arrows) in differentiated HepaRG cells and 4-5 days human hepatocytes 
cultured in sandwich (SCHH) and conventional (CCHH) configuration were observed under 
phase-contrast microscopy (×20 magnification). (B) Pericanalicular F-actin microfilament 
network after labeling with phalloidin-fluoprobe in HepaRG cells (nuclei stained in blue using 
Hoechst dye) and 4-5 days human hepatocytes cultured in sandwich and conventional 
configuration. Imaging was done using Cellomics ArrayScan VTI HCS Reader (Thermo 
Scientific). (C) Electron microscopic micrograph of tight junctions surrounding bile canaliculus 
structures in HepaRG cells (arrows), original magnification: ×3000 (bar = 2µm). H: hepatocyte, 
BC: bile canaliculus. 
Fig. 2. Bile canaliculi networks in HepaRG cells and primary human hepatocytes. Bile 
canaliculi were labeled using CDFDA, a MRP2 substrate in (A) HepaRG cells, SCHH and 
CCHH. (B) The mean surface areas of bile canaliculi networks in HepaRG cells and 4-5 days 
human hepatocytes cultured in sandwich and conventional cultures were estimated by 
quantifying CDFDA-labeled lumen surfaces using vHCS.scan (V6.2.0) cellomics software 
(Thermo Scientific). Data represent the means ± SD of at least three independent experiments. 
Data with p < 0.05 is considered significant (*). 
Fig. 3. Bile canaliculi dynamics in HepaRG cells and human hepatocytes. Time-lapse 
imaging of HepaRG cells and 4-5 days human hepatocytes cultured in conventional configuration 
(CCHH). Time-dependent contraction/relaxation activity of bile canaliculi (arrows). Imaging was 
done using inverted microscope Zeiss Axiovert 200M and AxioCam MRm.  
Fig. 4. Distribution of main bile acid transporters in HepaRG cells and human hepatocytes. 
Differentiated HepaRG cells and 4-5 days sandwich (SCHH) and conventional (CCHH) cultures 
of human hepatocytes were fixed and incubated with primary antibodies against each of the 
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following hepatobiliary transporters: NTCP, MRP3, BSEP, MRP2, MDR1 and MDR3 (green 
fluorescence). Nuclei (blue) were labeled using Hoechst. Immunofluorescence images were 
obtained with a Cellomics ArrayScan VTI HCS Reader (Thermo Scientific). 
Fig. 5. Sodium-dependent activity of NTCP in HepaRG cells and human hepatocytes. 
HepaRG cells and 4-5 days sandwich (SCHH) and conventional (CCHH) cultures of human 
hepatocytes were incubated with [
3
H]-TCA for 30 minutes in the presence and absence of 
sodium ions. (A) NTCP activity was evaluated through measurement of the radiolabeled 
substrate TCA accumulated in cellular layers (cells plus bile canaliculi). Uptake of [
3
H]-TCA 
in each cell model was expressed relative to the levels found in cells incubated with Na
+
-free 
buffer, arbitrarily set at a value of 1. (B) NTCP activity was evaluated in the presence of Na
+ 
as the ratio of total radioactivity measured in cell lysates to total number of hepatocytes in 
each cell model. Calculations were based on 800.000 hepatocytes in the two primary 
hepatocyte models and 280.000 HepaRG hepatocytes per well. Results are expressed relative 
to NTCP activity found in HepaRG hepatocytes, arbitrarily set at a value of 1. Data represent 
the means ± SD of at least three independent experiments. Data with p < 0.05 is considered 
significant (*). 
Fig. 6. Functional activity of MRP2 in HepaRG cells and human hepatocytes. MRP2 activity 
was estimated using CDFDA in HepaRG cells and 4-5 days sandwich (SCHH) and conventional 
(CCHH) cultures of human hepatocytes. Efflux of fluorescent CDF, a substrate of MRP2, 
characterized by accumulation of green fluorescence into bile canaliculi, was evaluated in 
standard and Ca
2+
- and Mg
2+
- free buffer in the presence and absence of MK571, an inhibitor of 
MRP2. Imaging was done using inverted microscope Zeiss Axiovert 200M and AxioCam MRm.  
Fig. 7. MDRs activity in HepaRG cells. HepaRG cells were incubated for 30 minutes in the 
presence or absence of 50µM verapamil, an inhibitor of MDRs, before 30 minute-incubation with 
7µM JC-1. A significant intracellular accumulation resulting in the formation of JC-1 dimers 
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characterized by red fluorescence was observed in HepaRG hepatocytes. Imaging was done using 
Cellomics ArrayScan VTI HCS Reader (Thermo Scientific). 
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Fig. 1. Bile canaliculi networks in HepaRG cell and human hepatocyte cultures. (A) Bile canaliculi structures 
(arrows) in differentiated HepaRG cells and 4-5 days human hepatocytes cultured in sandwich (SCHH) and 
conventional (CCHH) configuration were observed under phase-contrast microscopy (×20 magnification). 
(B) Pericanalicular F-actin microfilament network after labeling with phalloidin-fluoprobe in HepaRG cells 
(nuclei stained in blue using Hoechst dye) and 4-5 days human hepatocytes cultured in sandwich and 
conventional configuration. Imaging was done using Cellomics ArrayScan VTI HCS Reader (Thermo 
Scientific). (C) Electron microscopic micrograph of tight junctions surrounding bile canaliculus structures in 
HepaRG cells (arrows), original magnification: ×3000 (bar = 2µm). H: hepatocyte, BC: bile canaliculus.  
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Fig. 2. Bile canaliculi networks in HepaRG cells and primary human hepatocytes. Bile canaliculi were labeled 
using CDFDA, a MRP2 substrate in (A) HepaRG cells, SCHH and CCHH. (B) The mean surface areas of bile 
canaliculi networks in HepaRG cells and 4-5 days human hepatocytes cultured in sandwich and conventional 
cultures were estimated by quantifying CDFDA-labeled lumen surfaces using vHCS.scan (V6.2.0) cellomics 
software (Thermo Scientific). Data represent the means ± SD of at least three independent experiments. 
Data with p < 0.05 is considered significant (*).  
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Fig. 3. Bile canaliculi dynamics in HepaRG cells and human hepatocytes. Time-lapse imaging of HepaRG cells 
and 4-5 days human hepatocytes cultured in conventional configuration (CCHH). Time-dependent 
contraction/relaxation activity of bile canaliculi (arrows). Imaging was done using inverted microscope Zeiss 
Axiovert 200M and AxioCam MRm.  
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Fig. 4. Distribution of main bile acid transporters in HepaRG cells and human hepatocytes. Differentiated 
HepaRG cells and 4-5 days sandwich (SCHH) and conventional (CCHH) cultures of human hepatocytes were 
fixed and incubated with primary antibodies against each of the following hepatobiliary transporters: NTCP, 
MRP3, BSEP, MRP2, MDR1 and MDR3 (green fluorescence). Nuclei (blue) were labeled using Hoechst. 
Immunofluorescence images were obtained with a Cellomics ArrayScan VTI HCS Reader (Thermo Scientific). 
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Fig. 5. Sodium-dependent activity of NTCP in HepaRG cells and human hepatocytes. HepaRG cells and 4-5 
days sandwich (SCHH) and conventional (CCHH) cultures of human hepatocytes were incubated with [3H]-
TCA for 30 minutes in the presence and absence of sodium ions. (A) NTCP activity was evaluated through 
measurement of the radiolabeled substrate TCA accumulated in cellular layers (cells plus bile canaliculi). 
Uptake of [3H]-TCA in each cell model was expressed relative to the levels found in cells incubated with 
Na+-free buffer, arbitrarily set at a value of 1. (B) NTCP activity was evaluated in the presence of Na+ as 
the ratio of total radioactivity measured in cell lysates to total number of hepatocytes in each cell model. 
Calculations were based on 800.000 hepatocytes in the two primary hepatocyte models and 280.000 
HepaRG hepatocytes per well. Results are expressed relative to NTCP activity found in HepaRG hepatocytes, 
arbitrarily set at a value of 1. Data represent the means ± SD of at least three independent experiments. 
Data with p < 0.05 is considered significant (*).  
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Fig. 6. Functional activity of MRP2 in HepaRG cells and human hepatocytes. MRP2 activity was estimated 
using CDFDA in HepaRG cells and 4-5 days sandwich (SCHH) and conventional (CCHH) cultures of human 
hepatocytes. Efflux of fluorescent CDF, a substrate of MRP2, characterized by accumulation of green 
fluorescence into bile canaliculi, was evaluated in standard and Ca2+- and Mg2+- free buffer in the presence 
and absence of MK571, an inhibitor of MRP2. Imaging was done using inverted microscope Zeiss Axiovert 
200M and AxioCam MRm.  
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Fig. 7. MDRs activity in HepaRG cells. HepaRG cells were incubated for 30 minutes in the presence or 
absence of 50µM verapamil, an inhibitor of MDRs, before 30 minute-incubation with 7µM JC-1. A significant 
intracellular accumulation resulting in the formation of JC-1 dimers characterized by red fluorescence was 
observed in HepaRG hepatocytes. Imaging was done using Cellomics ArrayScan VTI HCS Reader (Thermo 
Scientific).  
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